METHOD FOR CHARACTERISING TARGET COMPOUNDS
20220120682 · 2022-04-21
Inventors
Cpc classification
International classification
Abstract
Disclosed is a method for characterizing target compounds using an analyzing system comprising a measurement chamber intended to receive the target compounds contained in a fluid sample and in which a plurality of separate sensitive sites each comprise receivers able to interact with the target compounds. The method includes supplying a fluid sample, determining a measurement signal S.sub.k(t.sub.i) representative of the interactions between the target compounds and the receivers; computing a normed vector Sn(t.sub.i); and reiterating the determining and computing steps, while incrementing the measurement time, until a stability criterion is met, so as to obtain a characterization of the target compounds from the normed vector Sn(t.sub.i).
Claims
1. A method for characterizing target compounds, with an analyzing system comprising a measurement chamber intended to receive target compounds contained in a fluid sample, in which measurement chamber are located a plurality of distinct sensitive sites each comprising receptors that are able to interact with the target compounds, the method comprising the following steps: fluidically supplying a fluid sample to the measurement chamber, this comprising an injecting phase P.sub.2 in which the fluid sample is formed from a carrier fluid and the target compounds; determining, in the supplying step, at a measurement time t.sub.i, for each sensitive site, a measurement signal S.sub.k(t.sub.i) representative of the interactions between the target compounds and the receptors, k being the rank of the sensitive site in question, so as to obtain a measurement vector S(t.sub.i) formed from the measurement signals S.sub.k(t.sub.i) acquired at the measurement time t.sub.i; computing, at the measurement time t.sub.i, a normalized vector Sn(t.sub.i) from the measurement vector S(t.sub.i) at the measurement time t.sub.i, and from a norm ∥S(t.sub.i)∥ computed from the measurement vector S(t.sub.i) at the measurement time t.sub.i; and reiterating the steps of determining measurement signals and of computing the normalized vector, while incrementing the measurement time, until a stability criterion is met, so as to obtain a characterization of the target compounds on the basis of the normalized vector Sn(t.sub.i) at the measurement time t.sub.i.
2. The method as claimed in claim 1, wherein: the fluid-supplying step comprises, prior to the injecting phase P2, an initial phase P.sub.1 in which the fluid sample is formed from the carrier fluid without the target compounds; the step of determining the measurement signal S.sub.k(t.sub.i) comprises computing a useful vector Su(t.sub.i), at the measurement time t.sub.i, by subtracting from the measurement vector S(t.sub.i) a reference vector S(Δt.sub.ref) determined in the initial phase P1 in a predetermined measurement period Δt.sub.ref; and the normalized vector Sn(t.sub.i) being computed from the useful vector Su(t.sub.i).
3. The method as claimed in claim 1, wherein the step of determining the measurement signal S.sub.k(t.sub.i) comprises computing a corrected vector Sc(t.sub.i) from the measurement vector S(t.sub.i) with application of a low-pass filter or from a sum of the values of the measurement vector S(t.sub.i) at the previous measurement times.
4. The method as claimed in claim 1, wherein the stability criterion comprises a comparison, at the measurement time t.sub.i, of a stability parameter P.sub.st(t.sub.i) computed from the coordinates Sn.sub.k(t.sub.i) of the normalized vector Sn(t.sub.i) in a moving window t.sub.i-T.sub.st, to a determined threshold value P.sub.st,th.
5. The method as claimed in claim 4, wherein the stability parameter P.sub.st(t.sub.i) is the maximum among the variances computed at the measurement time t.sub.i for the coordinates Sn.sub.k(t.sub.i-T.sub.st) of the normalized vector Sn in a moving window t.sub.i-T.sub.st.
6. The method as claimed in claim 1, wherein the stability criterion comprises a comparison, at the measurement time t.sub.i, of an injection parameter P.sub.inj(t.sub.i) computed from the coordinates S.sub.k(t.sub.i) of the measurement vector S(t.sub.i) in a moving window t.sub.i-T.sub.inj, to a determined threshold value P.sub.inj,th.
7. The method as claimed in claim 6, wherein the injection parameter P.sub.inj(t.sub.i) is the maximum among the variances computed at the measurement time t.sub.i for the coordinates S.sub.k(t.sub.i-T.sub.inj) of the measurement vector S in a moving window t.sub.i-T.sub.inj.
8. The method as claimed in claim 1, wherein the norm ∥S(t.sub.i)∥ is the Euclidean norm.
9. The method as claimed in claim 1, wherein the characterizing step comprises providing at least one parameter characteristic of a variation as a function of time in the Euclidean norm of the normalized vector Sn in the injecting phase P2.
10. The method as claimed in claim 9, wherein the characterizing step comprises computing an integral, over the duration of the injecting phase P2, of the Euclidean norm of the normalized vector Sn.
11. The method as claimed in claim 1, wherein the analyzing system is an electronic nose based on surface-plasmon-resonance imaging, or is an analyzing system comprising a plurality of distinct electromechanical resonators each forming one sensitive site.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0033] Other aspects, aims, advantages and features of the disclosure will become more clearly apparent on reading the following detailed description of preferred embodiments thereof, this description being given by way of nonlimiting example and with reference to the accompanying drawings, in which:
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
DETAILED DESCRIPTION
[0041] In the figures and in the remainder of the description, the same references have been used to designate identical or similar elements. In addition, the various elements have not been shown to scale so as to improve the clarity of the figures. Moreover, the various embodiments and variants are not mutually exclusive and may be combined with one another. Unless otherwise indicated, the terms “substantially,” “about” and “of the order of” mean to within 10%, and preferably to within 5%.
[0042] The disclosure relates to characterizing target compounds contained in a fluid sample by means of an analyzing system comprising a measuring device, a fluid-supplying device and a processing unit. As detailed below, the measuring device comprises a measurement chamber that is suitable for receiving a fluid (gaseous or liquid) sample comprising the target compounds, in which measurement chamber are located a plurality of distinct sensitive sites, each comprising at least one receptor suitable for interacting, by adsorption/desorption, with the target compounds.
[0043] In the remainder of the description, the analyzing system is an electronic nose based on surface-plasmon-resonance (SPR) imaging. However, other characterization technologies may be used. In this regard, the analyzing system may, as an alternative to the electronic nose, comprise MEMS resonators (MEMS being the acronym of micro-electro-mechanical system) or NEMS resonators (NEMS being the acronym of nano-electro-mechanical system). This type of technology is known to those skilled in the art, and an example of such an analyzing system is described in document EP3184485. The analyzing system comprises a plurality of electromechanical resonators that are distinct from one another, a surface of each resonator being functionalized by the presence of receptors, and thus forming a sensitive site. In a known manner, the interactions between the target compounds and the receptors of a sensitive site cause a modification of the resonant frequency of the electromechanical resonator. In a similar way to the SPR technology of the electronic nose, measuring the variation in the resonant frequency thus allows a measurement signal S.sub.k(t.sub.i) representative of the interactions between the target compounds and the receptors of the sensitive site of rank k in question, to be obtained. The variation in the resonant frequency may be measured via a piezoresistive or capacitive measurement, inter alia.
[0044] Generally, by characterization, what is meant is obtaining information representative of the interactions of the target compounds contained in the fluid sample with the receptors of various sensitive sites of the analyzing system. The interactions in question are here events resulting in the target compounds adsorbing on and/or desorbing from the receptors. This information thus forms an interaction pattern, or in other words a “signature” of the target compounds, this pattern being representable, for example, in the form of a histogram or of a radar chart. More precisely, in the case where the analyzing system comprises N distinct sensitive sites, the interaction pattern is formed by N representative items of information, these being formed of a value correlated to the intensity of a measurement optical signal obtained for the sensitive site in question.
[0045] Generally, the target compounds are elements intended to be characterized by the electronic nose, and contained in a fluid sample. They may be, by way of illustration, bacteria, viruses, proteins, lipids, volatile organic molecules, inorganic compounds, inter alia. Moreover, the receptors are elements that are fastened to the sensitive sites and that exhibit a capacity for interaction with the target compounds, though the chemical and/or physical affinities between the sensitive compounds and the receptors are not necessarily known. The receptors of the various sensitive sites preferably have different physico-chemical properties, which have an impact on their ability to interact with the target compounds. It may be a question, by way of example, of amino acids, peptides, nucleotides, polypeptides, proteins, organic polymers, inter alia.
[0046] With reference to
[0047] The electronic nose 1 comprises, located in a measurement chamber 4 intended to receive the gaseous sample to be analyzed, a plurality of sensitive sites 6 that are distinct from one another, each formed from receptors that are able to interact with the target compounds to be studied and therefore able to interact in a differentiated manner with the sample. The sensitive sites 6 are distinct from one another in the sense that they comprise receptors that are different, in terms of chemical or physical affinity with respect to the target compounds to be analyzed, and are therefore intended to deliver interaction information that differs from one sensitive site 6 to the next. The sensitive sites 6 are distinct regions of a measurement carrier 5, and may be contiguous or spaced apart from one another. The electronic nose 1 may further comprise a plurality of identical sensitive sites 6, for example with the aim of detecting any measurement drift or of identifying a defective sensitive site.
[0048] The electronic nose comprises an optical measuring device 3 of SPR-imaging type, allowing, for each sensitive site 6, the interactions of the target compounds with the receptors to be quantified, here via measurement of the intensity of an optical signal associated with the sensitive site 6 in question, this optical signal being a portion, here a reflected portion, of the exciting light radiation emitted by a light source. The intensity of the measured optical signal is directly correlated with the interactions between the target compounds and the receptors.
[0049] In the context of measurement by SPR imaging, the optical measuring device 3 is suitable for acquiring, in real time, light radiation originating from all of the sensitive sites 6. Thus, the optical signals emitted by the plurality of sensitive sites 6 are measured together and in real time, in the form of an image acquired by the same optical sensor 8.
[0050] Thus, the optical measuring device 3 comprises a light source 7 suitable for transmitting so-called exciting light radiation in the direction of sensitive sites 6, and for generating surface plasmons on the measurement carrier 5. The light source 7 may be formed from a light-emitting diode, the emission spectrum of which has an emission peak centered on a central wavelength λ.sub.c. Various optical elements (lenses, polarizer, etc.) may be placed between the light source 7 and the measurement carrier 5.
[0051] The optical measuring device 3 further comprises an image sensor 8, i.e., a matrix-array optical sensor suitable for collecting an image of the light radiation that originates from the sensitive sites in response to the exciting light radiation. The image sensor 8 is a matrix-array photodetector, a CMOS or CCD sensor for example. It therefore comprises a matrix array of pixels the spatial resolution of which is such that, preferably, a plurality of pixels acquires a portion of the reflected light radiation associated with a given sensitive site 6.
[0052] The processing unit (not shown) allows the processing operations described below in the context of the characterizing method to be implemented. It may comprise at least one microprocessor and at least one memory. It is connected to the optical measuring device 3, and more precisely to the image sensor 8. It comprises a programmable processor able to execute instructions stored on a data storage medium. It further comprises at least one memory containing the instructions required to implement the characterizing method. The memory is also suitable for storing the information computed at each measurement time.
[0053] As described below, the processing unit is notably suitable for storing and processing a plurality of images, called elementary images, acquired at a given sampling frequency f.sub.e in a measurement period Δt, in order to determine, at the current time t.sub.i, an optical measurement signal S.sub.k(t.sub.i) associated with the sensitive site of rank k.
[0054] The fluid-supplying device 2 is suitable for supplying the measurement chamber 4 with gaseous samples, formed from a carrier gas with or without target compounds. As mentioned above, the fluid samples may, as a variant, be in the liquid phase (carrier liquid, with or without target compounds). To this end, the device comprises a reservoir of carrier gas, and a source of target compounds. It may comprise a plurality of fluid lines, connected to the inlet of the measurement chamber 4, and may comprise valves and mass flow regulators. It thus allows the measurement chamber 4 to be supplied with at least one carrier gas without target compounds, for example in the initial phase and the dissociating phase, and allows the target compounds to be injected in the injecting phase. It may be able to ensure that the concentration of the target compounds in the measurement chamber remains constant over time, or not.
[0055]
[0056] A sensorgram corresponds to the variation as a function of time in a signal representative of the interactions between the target compounds and the receptors of a sensitive site. In this example, it is a question of the intensity of an optical signal Su.sub.k(t), called the useful signal, associated with the sensitive site of rank k, and more precisely here a question of the variation in reflectivity ΔR corresponding to the modification of the refractive index, of the sensitive site of rank k in question, related to the adsorption and desorption interactions of the target compounds with the receptors of the sensitive site.
[0057] In a known manner, a conventional-profile sensorgram exhibits an initial phase P1, a phase P2 of injecting target compounds, then a dissociating phase P3. The intensity of the sensorgram signal is proportional to the number of receptors of the sensitive site in question.
[0058] The initial phase P1 corresponds to the introduction into the measurement chamber of the carrier fluid alone, without target compounds. The sensorgrams thus represent a reference signal characteristic of the measurement environment. This reference signal is intended to be subsequently subtracted from the measurement signal to thus obtain a useful signal representative of the interactions of the target compounds.
[0059] The phase P2 of injecting target compounds corresponds to the introduction, into the measurement chamber, of a fluid sample formed from the carrier fluid and from the target compounds. This phase comprises a transient assimilation state P2.1 followed by a steady equilibrium state P2.2.
[0060] The transient assimilation state P2.1 corresponds to the gradual but exponential increase (Langmuir's law) in the interactions between the target compounds and the receptors, as the target compounds are injected into the measurement chamber. The exponential growth of the sensorgrams in the assimilation state is due to the fact that there are, then, many more adsorption events than desorption events.
[0061] It will be noted that, in this regard, the interaction between a target compound A (A standing for analyte) and a receptor L (L standing for ligand) is a reversible effect characterized by a constant k.sub.a (in mol.sup.−1.s.sup.−1) of adsorption of the target compound A on the receptor L to form a target compound/receptor LA (LA standing for ligand-analyte), and by a constant k.sub.b (in s.sup.−1) of desorption corresponding to the dissociation of the compound LA. The ratio k.sub.d/k.sub.a forms the equilibrium dissociation constant k.sub.D (in mol) that gives the value of the concentration c.sub.A of target compounds A allowing 50% of the receptors L to be saturated.
[0062] The steady equilibrium state P2.2 is reached when the concentration c.sub.LA(t) in compounds LA remains constant dc.sub.LA/dt=0, i.e., when the product of the constant k.sub.a and the concentrations of target compounds c.sub.A(t) and of receptors c.sub.L(t) (number of adsorption events) is equal to the product of the constant k.sub.d and the concentration c.sub.LA(t) of compounds LA (number of desorption events), or in other words when the following rate equation is respected dc.sub.LA/dt=k.sub.a×c.sub.A×c.sub.L−k.sub.d×c.sub.LA=0. The maximum steady-state value of the response signal is proportional to the concentration c.sub.A(t) of target compounds A. Saturation of the receptors L at the sensitive site may be achieved when the concentration c.sub.A of target compounds A is sufficient.
[0063] The dissociating phase P3 corresponds to a step of removing the target compounds present in the measurement chamber, so that the concentration of compounds LA decreases, usually exponentially.
[0064] It should be clear from the rate equation indicated above that the steady equilibrium state P2.2 requires the concentration c.sub.A(t) of target compounds A in the measurement chamber to remain constant in the injecting step P2. The equilibrium state cannot therefore be reached when the concentration c.sub.A(t) of target compounds A varies over time. This therefore requires the fluid-supplying device of the electronic nose to be able to precisely control the concentration c.sub.A(t) of the target compounds in the measurement chamber, and the characterizing method to comprise a rigorous protocol for fluidically managing the target compounds, as well as strict and controlled operating conditions.
[0065]
[0066] The sensorgrams Su.sub.k(t) are obtained in a fluid-supplying step that also comprises an initial phase P1, a phase P2 of injecting the target compounds and a dissociating phase P3. The initial and dissociating phases P1, P3 are here similar to those described above. In contrast, in the injecting phase P2, it may be seen that the sensorgrams Su.sub.k(t) exhibit large intensity variations, and hence it is possible neither to identify any transient assimilation state P2.1 nor to identify a steady equilibrium state P2.2.
[0067] This type of degraded sensorgram profiles may be representative of a situation in which the concentration c.sub.A(t) of target compounds within the measurement chamber varies over time. A steady state of equilibrium between the rates at which the target compounds adsorb on and desorb from the receptors cannot then be obtained. These sensorgrams may be obtained by means of a simplified fluid-supplying device that does not allow the value of the concentration c.sub.A(t) over time to be controlled, and notably when the electronic nose is used under real, uncontrolled conditions, when the target compounds do not have a constant concentration c.sub.A(t). By way of example, it may thus be a question of injection of an odor present in the open air and the concentration of which cannot be controlled.
[0068] The characterizing method according to the disclosure allows the target compounds to be characterized on the basis of sensorgrams having conventional or degraded profiles, i.e., whether the concentration c.sub.A(t) of the target compounds in the measurement chamber is constant or not. This characterizing method further has the advantage of being able to provide additional information relative to the target compounds, such as an instantaneous interaction intensity I.sub.int(t.sub.i) representative of the instantaneous population of target compounds adsorbed by the receptors, and a total level of exposure of the receptors to the target compounds in the period of the injecting phase P2. The “instantaneous” character is here relative to the integration time of the image sensor, its acquisition period Δt, etc., and not to the effective characteristic times of the (much faster) physical adsorption/desorption effects.
[0069]
[0070] In a first step 100, the fluid supply of the measurement chamber of the electronic nose with a gaseous sample is activated. This step comprises an initial first phase P1, a phase P2 of injecting target compounds, then a dissociating phase P3.
[0071] In this example, the fluid-supplying device is suitable for injecting target compounds into the measurement chamber without the concentration c.sub.A(t) necessarily remaining constant. The concentration c.sub.A(t) may remain constant, just as it may exhibit substantial variations as a function of time. In any case, the concentration c.sub.A(t) is assumed to remain constantly above a minimum concentration corresponding to the detection limit of the electronic nose. Thus, the injecting phase does not necessarily exhibit a steady equilibrium state.
[0072] The following steps of determining the measurement signals and of processing the data are carried out in the fluid-supplying step, and reiterated for a plurality of successive measurement times t.sub.i, until a stability criterion is met. With each iteration i is thus associated one measurement time t.sub.i, also called the current time.
[0073] In a step 200, for each sensitive site of rank k ranging from 1 to N, at the current time t.sub.i, a measurement signal S.sub.k(t.sub.i) representative of the interactions between the target compounds and the receptors is determined, at a measurement time t.sub.i, in order thus to obtain a measurement vector S(t.sub.i).
[0074] More precisely, the image sensor acquires, in a period Δt separating two successive measurement times t.sub.i−1 and t.sub.i, a plurality of images Ie.sub.m, called elementary images, of the matrix array of N distinct sensitive sites, m being the acquisition rank of the elementary image Ie, at a sampling frequency f.sub.e. The sampling frequency f.sub.e may be 10 images per second, and the acquisition period Δt may be a few seconds, 4 s for example.
[0075] For each elementary image Ie.sub.m, the processing unit determines an elementary optical intensity value (s.sub.k).sub.m by taking the average of the optical intensity (s.sub.k(i,j)).sub.m acquired by each pixel i, j associated with a given sensitive site of rank k, and computes an average value (
[0076] A measurement vector S(t.sub.i) is thus obtained, at the current time t.sub.i, the coordinates [S.sub.1(t.sub.i), . . . , S.sub.k(t.sub.i), . . . S.sub.N(t.sub.i)] of which are the measurement signals of the sensitive sites at the current time t.sub.i, and hence it is possible to write: S(t.sub.i)=[S.sub.k(t.sub.i)].sub.k=1,N.
[0077] In a step 300, a useful vector Su(t.sub.i) is advantageously computed sat the current time t.sub.i, by subtracting from the measurement vector S(t.sub.i) determined beforehand a reference value acquired for each sensitive site k in the initial phase P1, so that Su(t.sub.i)=S(t.sub.i)−S(Δt.sub.ref)=[S.sub.k(t.sub.i)].sub.k=1,N−[S.sub.k(Δt.sub.ref)].sub.k=1,N. The reference period Δt.sub.ref is, for example, equal to several times the acquisition period Δt in the initial phase P1, and may be a period that directly precedes the injecting phase P2. Thus, information associated with the carrier gas alone, given by S(Δt.sub.ref), is subtracted from the information contained in S(t.sub.i), allowing information related essentially to the interactions between the target compounds and the receptors to be revealed.
[0078] In a step 400, a normalized vector Sn(t.sub.i) at the current time t.sub.i is computed from the measurement vector S(t.sub.i) at the current time t.sub.i and from a norm of the measurement vector S(t.sub.i) at the current time t.sub.i. Preferably, the ratio between the useful vector Su(t.sub.i) at the current time t.sub.i and a norm ∥Su(t.sub.i)∥ thereof at the current time t.sub.i is computed.
[0079] It will be noted that, generally, the norm of order p of a vector S of size N and of coordinates [S.sub.k].sub.k=1,N is defined by the following relationship: ∥S∥.sub.p=(Σ.sub.k=1,N |S.sub.k|.sup.p).sup.1/p, with p a non-zero, positive integer or decimal number. Thus, the norm 1 corresponds to the sum of the absolute value of the coordinates of the vector S, and the norm 2 corresponds to the Euclidean norm.
[0080] In this example, the Euclidean norm (norm 2) is preferably used. Thus, the normalized vector Sn(t.sub.i) at the current time t.sub.i is computed via the following relationship:
[0081] Preferably, the useful vector Su(t.sub.i) at the current time t.sub.i may have been processed beforehand to obtain a vector Sc(t.sub.i), called the corrected vector, from which noise has been at least partially filtered and/or the signal-to-noise ratio of which has been increased. Thus, by way of example, the corrected vector Sc(t.sub.i) may be obtained by applying a classical low-pass filter to the useful vector Su(t.sub.i), or even, as a variant, by computing the sum of the preceding measurement times: Sc(t.sub.i)=Su(t.sub.i)+Sc(t.sub.i−1).
[0082] As described below, it turns out, surprisingly, that sensorgrams formed on the basis of such a normalized vector Sn(t.sub.i) exhibit, during the injecting phase P2, a transient portion of a particularly short duration, followed by a steady-state portion. It will be noted that these transient and steady-state portions do not correspond to the assimilation and equilibrium states described above, insofar as, in the injecting phase, equilibrium is not reached between the rates at which the target compounds adsorb on and desorb from the receptors. Nonetheless, it is however possible to characterize the target compounds on the basis of the steady-state portion of the sensorgrams Sn.sub.k(t.sub.i).
[0083] In a step 500, a stability criterion is computed that is such that, once it is met, the characterizing method may start to characterize the target compounds, i.e., to generate an interaction pattern, for example one taking the form of a histogram or a radar chart, from the coordinates of the normalized vector Sn(t.sub.i) at the current time t.sub.i. In this example, the stability criterion is met when the normalized vector Sn(t.sub.i) exhibits a sufficient stability as a function of time in the injecting phase P2.
[0084] Thus, an advantageous first sub-step 510 may consist in identifying the injecting phase P2 in the fluid-supplying step. To this end, one approach is to determine a parameter P.sub.inj(t.sub.i), called the injection parameter, at the current time t.sub.i. This injection parameter P.sub.inj(t.sub.i) may be defined as being equal to the maximum of the variance V.sub.k, computed, at the current time t.sub.i, in a moving window t.sub.i-T.sub.inj, of the useful signals Su.sub.k(t.sub.i) (or of the corrected signals Sc.sub.k(t.sub.i)). The period T.sub.inj of the moving window is equal to a plurality of times the acquisition period Δt, and for example is equal to 5×Δt. Thus, the injection parameter is written:
Other formulations of the injection parameter are also possible (average of a time difference, etc.).
[0085] The injecting phase may be said to be identified when the injection parameter P.sub.inj(t.sub.i) is higher than or equal to a threshold value P.sub.inj,th: P.sub.inj(t.sub.i)≥P.sub.inj,th. This threshold value P.sub.inj,th may be predetermined, for example from a pre-filled database relating to various target compounds, or may be determined during the characterizing method. In this regard, the threshold value P.sub.inj,th may be set, in the initial phase P1 of the supplying step, equal to the product of a coefficient and of the maximum of the values of the injection parameter P.sub.inj(t.sub.i) in a training period T.sub.learn, for example equal to 10 or 20 times Δt, in the initial phase P1. The coefficient may be equal to 1.02, 1.05, 1.10, inter alia. Thus,
is computed. Next, after this training period T.sub.learn, the threshold value P.sub.inj,th is set and remains constant throughout the fluid-supplying step. Retraining may then be carried out when the injection parameter falls and persistently remains below the threshold. This allows a reference that is advantageously more recent to be obtained.
[0086] Next, a second sub-step 520 may consist in determining the temporal stability of the normalized vector Sn(t.sub.i) in the fluid-supplying step. To this end, one approach is to determine a parameter P.sub.st(t.sub.i), called the stability parameter, at the current time t.sub.i. This stability parameter P.sub.st(t.sub.i) may be defined as being equal to the maximum of the variance V.sub.k, computed, at the current time t.sub.i, in a moving window t.sub.i-T.sub.st, of the useful signals Sn.sub.k(t.sub.i). The period T.sub.st of the moving window may be different from or equal to the period T.sub.inj, and may be equal to a plurality of times the acquisition period Δt, and for example is equal to 5×Δt. Thus, the stability parameter is written:
[0087] The temporal stability may be said to be sufficient when the stability parameter P.sub.st(t.sub.i) is lower than or equal to a threshold value P.sub.st,th: P.sub.st(t.sub.i)≤P.sub.st,th. This threshold value P.sub.st,th may be predetermined, for example from a pre-filled database relating to various target compounds, or may be determined during the characterizing method. In this regard, the threshold value P.sub.st,th may be set, in real time in the supplying step, equal to the product of a coefficient and of the maximum of the values of the stability parameter P.sub.st(t.sub.i) in the training period T.sub.learn in the initial phase P1. The coefficient may be equal to 1.02, 1.05, 1.10, inter alia. Thus,
is computed. Next, after this training period T.sub.learn, the threshold value P.sub.st,th is set and remains constant throughout the fluid-supplying step.
[0088] In the case where a single condition is met or no conditions are met, the stability criterion is not met and the method reiterates steps 200 to 500 of acquiring images and processing data. Thus, in the case where P.sub.inj(t.sub.i)<P.sub.inj,th, the supplying step is considered to still be in the initial phase P1 of the fluid-supplying step, and the gas sample is therefore considered to contain only the carrier gas and not yet the target compounds. In the case where P.sub.st(t.sub.i)>P.sub.st,th, the supplying step is considered to be in the injecting phase P2 of the fluid-supplying step, and the gas sample is therefore considered to contain the target compounds, but that the temporal stability of the normalized vector Sn(t.sub.i) is considered to be insufficient to allow the target compounds to be characterized. In contrast, the stability criterion is said to be met when both the above conditions are met, namely when P.sub.inj(t.sub.i)≥P.sub.inj,th, and when P.sub.st(t.sub.i)≤P.sub.st,th. The normalized vector Sn(t.sub.i) is then considered to have a sufficient stability to allow the target compounds then present in the gas sample to be characterized, and the method passes to the next step of generating the interaction pattern.
[0089] In a step 600, the target compounds are characterized on the basis of the normalized vector Sn(t.sub.i) at the current time t.sub.i. It is then a question of generating a representation, taking the form of a histogram or radar chart, inter alia, of the coordinates Sn.sub.k(t.sub.i) of the normalized vector at the current time t.sub.i, which corresponds to the final measurement time. Advantageously, the method for characterizing target compounds allows, in addition to the interaction pattern, additional information, such as the total number of interactions between the target compounds and the receptors in the injecting phase P2, and the variation as a function of time in an interaction intensity, to be generated. In this regard, the interaction intensity I.sub.int(t.sub.i) at the current time t.sub.i corresponds, for example, to the Euclidean norm (norm 2) of the normalized vector Sn(t.sub.i), and the total number of interaction corresponds to the integral, over the injecting phase P2, of the intensity of interaction I.sub.int(t.sub.i).
[0090] Thus, as detailed below, the characterizing method allows an interaction pattern describing the interaction of the target compounds with the receptors of the sensitive sites to be generated in a faster and simpler manner than in the case of the example of the prior art mentioned above. Specifically, it turns out that the normalized vector Sn(t.sub.i) exhibits a steady-state portion in the phase P2 of injecting the target compounds. The interaction pattern may therefore be obtained on the basis of the normalized vector Sn(t.sub.i) as soon as the stability criterion indicates that the steady-state portion has been reached. It would therefore appear, in this regard, that this steady-state portion is preceded by a very short transient portion, which reflects the start of the injecting phase P2. It is thus possible to generate the interaction pattern in a short time, much shorter than in the case of the prior art insofar as it is no longer necessary to wait for the steady equilibrium state P2.2 to be reached.
[0091] In addition, the characterizing method may generate the interaction pattern even if the concentration c.sub.A(t) of target compounds in the measurement chamber is not constant, and therefore even if the sensorgrams do not exhibit the steady equilibrium state P2.2. It is thus possible to characterize the target compounds under “real conditions,” i.e., under simplified operating conditions and with a simplified fluid-supply protocol. This thus simplifies the characterizing method, and also decreases the structural complexity of the fluid-supplying device, notably in terms of valves and of mass flow controller. Simultaneously, this normalized indicator provides access to a window onto the competition that could occur in the inter-site kinetics and be a characteristic of the target compounds studied.
[0092]
[0093]
[0094]
[0095]
[0096] Additional information may also be deduced from the normalized vector Sn(t.sub.i). Thus, some coordinates Sn.sub.k(t.sub.i) may exhibit a steady gradient (substantially constant slope), in the injecting phase P2. The value of the slope may also participate in the characterization of the target compounds. These parameters may be determined in a given period of the injecting phase P2.
[0097] Particular embodiments have just been described. Various modifications and variants will appear obvious to anyone skilled in the art.
[0098] As mentioned previously, the fluid sample containing the target compounds may be gaseous or liquid. The characterizing method is preferably implemented with gas samples by an electronic nose based on SPR imaging, but other analysis technologies may be implemented, such as analysis with electromechanical NEMS or MEMS resonators.